Trial Profile
A Retrospective, Non-interventional Study of Patients With T4 Tumours Comparing the Thyroid Remnant Ablation Success Following Thyrogen and 131I Administration Versus Thyroid Hormone Withdrawal and 131I Administration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Thyrotropin alfa (Primary) ; Iodine-131
- Indications Thyroid cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 07 Jan 2013 New trial record